Logo for Alto Neuroscience Inc

Alto Neuroscience Investor Relations Material

Latest events

Logo for Alto Neuroscience Inc

Investor Day 2024

Alto Neuroscience
Logo for Alto Neuroscience

Q3 2024

12 Nov, 2024
Logo for Alto Neuroscience

Investor Day 2024

9 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Alto Neuroscience Inc

Access all reports
Alto Neuroscience Inc. is a clinical-stage biopharmaceutical company based in the United States, focusing on developing precision medicine for psychiatric conditions. The company leverages AI-derived brain biomarkers to tailor psychiatric drug development to individual patients, aiming to improve treatment effectiveness for mental health issues. Their approach integrates detailed patient-specific data to optimize the drug development process. Alto Neuroscience has a range of products in clinical trials targeting conditions such as major depressive disorder and post-traumatic stress disorder. The company is headquartered in Los Altos, California, and its shares are listed on the NYSE under the ticker ANRO.